
Iovance Biotherapeutics Inc is a biotechnology business based in the US. Iovance Biotherapeutics shares (IOVA) are listed on the NASDAQ and all prices are listed in US Dollars. Iovance Biotherapeutics employs 319 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Iovance Biotherapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IOVA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Iovance Biotherapeutics stock price (NASDAQ: IOVA)
Use our graph to track the performance of IOVA stocks over time.Iovance Biotherapeutics shares at a glance
Latest market close | $11.47 |
---|---|
52-week range | $6.18 - $27.96 |
50-day moving average | $12.10 |
200-day moving average | $17.38 |
Wall St. target price | $30.77 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.30 |
Buy Iovance Biotherapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Iovance Biotherapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Iovance Biotherapeutics price performance over time
Historical closes compared with the close of $11.47 from 2022-07-01
1 week (2022-06-28) | 4.46% |
---|---|
1 month (2022-06-03) | 46.11% |
3 months (2022-04-01) | N/A |
6 months (2022-01-05) | -31.81% |
1 year (2021-07-02) | -56.65% |
---|---|
2 years (2020-07-02) | -60.57% |
3 years (2019-07-05) | 24.53 |
5 years (2017-07-05) | 57.12% |
Iovance Biotherapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -30.9% |
Return on equity TTM | -59.76% |
Profit margin | 0% |
Book value | $3.51 |
Market capitalisation | $1.8 billion |
TTM: trailing 12 months
Iovance Biotherapeutics share dividends
We're not expecting Iovance Biotherapeutics to pay a dividend over the next 12 months.
Have Iovance Biotherapeutics's shares ever split?
Iovance Biotherapeutics's shares were split on a 1:100 basis on 25 September 2013. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Iovance Biotherapeutics shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Iovance Biotherapeutics shares which in turn could have impacted Iovance Biotherapeutics's share price.
Iovance Biotherapeutics share price volatility
Over the last 12 months, Iovance Biotherapeutics's shares have ranged in value from as little as $6.18 up to $27.96. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Iovance Biotherapeutics's is 0.9061. This would suggest that Iovance Biotherapeutics's shares are less volatile than average (for this exchange).
Iovance Biotherapeutics overview
Iovance Biotherapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M. D.
Iovance Biotherapeutics in the news
Iovance (IOVA) Pipeline Aids Growth Amid Lack of Marketed Drugs
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Frequently asked questions
What percentage of Iovance Biotherapeutics is owned by insiders or institutions?Currently 0.47% of Iovance Biotherapeutics shares are held by insiders and 104.382% by institutions. How many people work for Iovance Biotherapeutics?
Latest data suggests 319 work at Iovance Biotherapeutics. When does the fiscal year end for Iovance Biotherapeutics?
Iovance Biotherapeutics's fiscal year ends in December. Where is Iovance Biotherapeutics based?
Iovance Biotherapeutics's address is: 825 Industrial Road, San Carlos, CA, United States, 94070 What is Iovance Biotherapeutics's ISIN number?
Iovance Biotherapeutics's international securities identification number is: US4622601007 What is Iovance Biotherapeutics's CUSIP number?
Iovance Biotherapeutics's Committee on Uniform Securities Identification Procedures number is: 37182R102
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert